SG
RPTX

StoneX Group’s Repare Therapeutics RPTX Stock Holding History

StoneX Group’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,603
Closed -$27.6K – 1192
2025
Q4 		$27.6K Buy
+10,603
New +$21.3K ﹤0.01% 959

StoneX Group's RPTX Position: Q1 2026 in Review

StoneX Group sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 10,603 shares — an estimated $27.6K sold.

StoneX Group first reported a position in RPTX in Q4 2025 and held it in 1 quarter. The position peaked at $27.6K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

  • StoneX Group reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 10,603 Repare Therapeutics shares in Q1 2026, an estimated $27.6K.
  • StoneX Group first reported a position in Repare Therapeutics in Q4 2025 and held it in 1 quarter.
  • StoneX Group's Repare Therapeutics position peaked at $27.6K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.